Human Epidermal Growth Factor Receptor 2

• HER2 is a protein on the surface of cells, part of the epidermal growth factor receptor family.
• It is involved in signaling pathways that regulate cell growth, division, and repair.
• Overexpression or amplification of the HER2 gene can lead to uncontrolled cell growth, often associated with certain cancers.
• Targeting HER2 has become a significant strategy in the treatment of HER2-positive cancers.
• Accurate testing for HER2 status is critical for guiding therapeutic decisions in oncology.

What is Human Epidermal Growth Factor Receptor 2 (HER2)?

Human Epidermal Growth Factor Receptor 2 (HER2) is a transmembrane protein that belongs to the epidermal growth factor receptor (EGFR) family, also known as the ErbB family of receptor tyrosine kinases. Located on the surface of various human cells, HER2 acts as a receptor, meaning it receives signals from outside the cell and transmits them inward, influencing cellular behavior. Unlike other members of its family, HER2 does not require a specific ligand (a molecule that binds to a receptor) to become activated. Instead, it prefers to form heterodimers (pairs) with other activated EGFR family members, significantly enhancing their signaling capabilities and promoting cell growth and survival.

The gene encoding this protein is called ERBB2. When the ERBB2 gene is amplified or overexpressed, it leads to an excessive number of HER2 proteins on the cell surface. This abundance can result in uncontrolled cell growth and division, a hallmark of cancer. For instance, HER2 overexpression is observed in approximately 15-20% of breast cancers and a subset of gastric cancers, making it a significant biomarker and therapeutic target in oncology. According to the American Cancer Society, about one in five breast cancers are HER2-positive, highlighting the prevalence and importance of this protein in cancer diagnostics and treatment strategies. Accurate identification of HER2 status is therefore a critical step in guiding appropriate therapeutic interventions for affected individuals.

HER2 Receptor Function and Role in Cell Development

The primary HER2 receptor function and significance lies in its involvement in cellular signaling pathways that regulate fundamental biological processes. These processes include cell growth, proliferation, differentiation, and survival. As a receptor tyrosine kinase, HER2 plays a critical role in transmitting signals from the extracellular environment to the cell’s interior. Upon activation, typically through dimerization with other ErbB receptors, HER2 initiates a cascade of intracellular signaling events. This leads to the phosphorylation of various proteins, which in turn activate downstream pathways such as the MAPK (mitogen-activated protein kinase) pathway and the PI3K/Akt (phosphatidylinositol 3-kinase/protein kinase B) pathway. The controlled activity of HER2 is vital for maintaining tissue homeostasis and proper organ development.

Understanding HER2 protein in human body is essential for comprehending its dual role in both normal physiological processes and disease development. In healthy cells, the precise regulation of HER2 signaling ensures that cells grow and divide only when necessary. For instance, HER2 contributes to:

• Embryonic Development: Essential for the proper formation of various tissues and organs during fetal growth.
• Cardiac Function: Plays a role in the development and maintenance of heart muscle cells.
• Nervous System Development: Involved in the growth and survival of neurons.
• Mammary Gland Development: Crucial for the normal development of breast tissue.

The HER2 role in cell growth and development becomes problematic when its activity is dysregulated. Overexpression or amplification of HER2 can lead to persistent activation of growth-promoting pathways, even in the absence of external growth factors. This continuous signaling drives uncontrolled cell proliferation, inhibits apoptosis (programmed cell death), and promotes angiogenesis (formation of new blood vessels), all of which are critical factors in tumor initiation and progression. The clinical significance of HER2 overexpression is profound, as it often correlates with more aggressive disease and poorer prognosis in certain cancers, but also makes these cancers susceptible to targeted therapies designed to block HER2 signaling. This understanding has revolutionized treatment approaches for HER2-positive cancers, offering patients more personalized and effective therapeutic options.